Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia [NA]
The ENERGIA study tests a personalized exercise program to reduce fatigue in patients with myeloproliferative neoplasms and chronic myeloid …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft [Phase 1]
A Stanford-sponsored Phase 1 trial is evaluating reduced-intensity, allogeneic hematopoietic cell transplantation with a T-cell–depleted gra…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT [Phase 1]
Phase 1 clinical trial update on DLI-X as a prophylactic and therapeutic donor lymphocyte infusion to prevent or treat leukemia relapse afte…
-
FDA approval · 2026-04-06FDA Approved: IMATINIB MESYLATE — Supplemental Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' supplemental application for Imatinib Mesylate (ANDA 212773), approving a generic version of the cancer…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 study evaluating pembrolizumab in combination with dasatinib, imatinib, or nilotinib for p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia [Phase 2]
Phase 2 study in chronic myeloid leukemia evaluating full treatment-free remission has completed and results are reported.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
A real-world study in China is evaluating how Scemblix (asciminib) is used to treat chronic myeloid leukemia in the chronic phase and is cur…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia [Phase 1]
A Phase 1a/1b study of ELVN-001 for chronic myeloid leukemia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
This clinical trial describes a study of patient characteristics, co-morbidities, and treatment patterns in chronic-phase chronic myeloid le…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant [Phase 1]
Phase 1 clinical trial evaluating CMV-MVA Triplex Vaccine to enhance CMV-specific immunity and prevent CMV viremia in patients undergoing ha…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide [Phase 1]
Phase 1 clinical trial update evaluating expanded/activated gamma delta T-cell infusion after hematopoietic stem cell transplantation with p…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients [Phase 3]
A clinical trial update indicating that Shenzhen TargetRx's investigational drug TGRX-678 is planned for a Phase 3 study in Chinese patients…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase [Phase 2]
A Phase 2 clinical trial evaluating asciminib as initial therapy for adults with chronic-phase chronic myeloid leukemia is currently recruit…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias [Phase 1]
Clinical trial update for CBX-250 in relapsed or refractory myeloid leukemias (Phase 1) that is currently recruiting at Crossbow Therapeutic…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
A clinical trial update describes a study investigating how personality traits influence adherence to tyrosine kinase inhibitor therapy in i…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib [Phase 2]
A Phase 2 trial is evaluating ponatinib hydrochloride as second-line therapy for chronic myeloid leukemia in chronic phase patients resistan…
-
EMA approval · 2026-03-06EMA Authorised: Sprycel (dasatinib) — Bristol-Myers Squibb Pharma EEIG
The EMA authorised Sprycel (dasatinib). It covers chronic myeloid leukemia (BCR-ABL positive) and precursor cell lymphoblastic leukemia-lymp…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Asciminib Roll-over Study [Phase 4]
This clinical trial update describes a Phase 4 roll-over study of asciminib for chronic myeloid leukemia that is currently recruiting.
-
EMA approval · 2026-03-05EMA Authorised: Imatinib Teva (imatinib) — Teva B.V.
EMA authorised Imatinib Teva (imatinib) for multiple indications including chronic myeloid leukemia, precursor cell lymphoblastic leukemia-l…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update evaluating TCRαβ-depleted progenitor cell graft with added memory T-cell donor lymphocyte infusion and selecti…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia [NA]
This clinical trial update describes a study evaluating how advanced practice nurses manage patients with chronic myeloid leukemia, currentl…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. [Phase 2]
A Phase II clinical trial evaluating the efficacy and safety of Asciminib in patients with newly diagnosed chronic myeloid leukemia in chron…
-
FDA approval · 2026-03-02FDA Approved: BOSULIF — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Bosulif (bosutinib) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2026-03-02FDA Approved: BOSULIF — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for BOSULIF (bosutinib) submitted by Pfizer Laboratories Div Pfizer Inc. The document does not speci…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies [Phase 2]
Phase 2 clinical trial update describing a donor stem cell transplant conditioning regimen with treosulfan, fludarabine, and total-body irra…